Bristol Myers Squibb Receives European Commission Approval of Zeposia for use in Adults with Moderately to Severely Active Ulcerative Colitis Pharmaceutical Investing
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BMY, CTXS, OWLT INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits Pharmaceutical Investing
Numinus to Host Q4 and 2021 Annual Results Conference Call on December 9, 2021 Pharmaceutical Investing
Follow-Up Data From Phase 3 Trial of Pfizer-BioNTech COVID-19 Vaccine Support Safety and High Efficacy in Adolescents 12 Through 15 Years of Age Pharmaceutical Investing
BMY, EAR, HEPS, HMLP INVESTOR ALERT BY CLAIMSFILER: Pending Lead Plaintiff Deadline in Class Action Lawsuits Pharmaceutical Investing
Arvinas and Pfizer Announce Updated Phase 1 Dose Escalation Data for ARV-471 to be Presented in Spotlight Poster Session at 2021 San Antonio Breast Cancer Symposium Life Science Investing
Pfizer and BioNTech Receive Expanded U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster to Include Individuals 18 and Older Pharmaceutical Investing
Allergan Aesthetics To Present Data From Its Leading Aesthetic Portfolio At The 2021 American Society For Dermatologic Surgery Virtual Meeting Pharmaceutical Investing
